• 1
    Lechler RI, Batchelor JR. Restoration of immunogenicity to passenger cell-depleted kidney allografts the addition of donor strain dendritic cells. J Exp Med 1982; 155: 3141.
  • 2
    Lechler R, Ng WF, Steinman RM. Dendritic cells in transplantation – friend or foe? Immunity 2001; 14: 357368.
  • 3
    Gershon RK, Kondo K. Cell interactions in the induction of tolerance: the role of thymic lymphocytes. Immunology 1970; 18: 723737.
  • 4
    Gershon RK, Kondo K. Infectious immunological tolerance. Immunology 1971; 21: 903914.
  • 5
    Sakaguchi S, Sakaguchi N, Asano M et al. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol 1995; 155: 11511164.
  • 6
    Asano M, Toda M, Sakaguchi N, Sakaguchi S. Autoimmune disease as a consequence of developmental abnormality of a T cell subpopulation. J Exp Med 1996; 184: 387396.
  • 7
    Thornton AM, Shevach EM. CD4+CD25+ immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production. J Exp Med 1998; 188: 287296.
  • 8
    Hall BM, Pearce NW, Gurley KE, Dorsch SE. Specific unresponsiveness in rats with prolonged cardiac allograft survival after treatment with cyclosporine. III. Further characterization of the CD4+ suppressor cell and its mechanisms of action. J Exp Med 1990; 171: 141157.
  • 9
    Hara M, Kingsley CI, Niimi M et al. IL-10 is required for regulatory T cells to mediate tolerance to alloantigens in vivo. J Immunol 2001; 166: 37893796.
  • 10
    Taylor PA, Noelle RJ, Blazar BR. CD4 (+) CD25 (+) immune regulatory cells are required for induction of tolerance to alloantigen via costimulatory blockade. J Exp Med 2001; 193: 13111318.
  • 11
    Gregori S, Casorati M, Amuchastegui S et al. Regulatory T cells induced by 1 alpha,25-dihydroxyvitamin D3 and mycophenolate mofetil treatment mediate transplantation tolerance. J Immunol 2001; 167: 19451953.
  • 12
    Sanchez-Fueyo A, Weber M, Domenig C et al. Tracking the immunoregulatory mechanisms active during allograft tolerance. J Immunol 2002; 168: 22742281.
  • 13
    Graca L, Cobbold SP, Waldmann H. Identification of regulatory T cells in tolerated allografts. J Exp Med 2002; 195: 16411646.
  • 14
    Bendelac A, Rivera MN, Park SH, Roark JH. Mouse CD1-specific NK1 T cells. development, specificity, and function. Ann Rev Immunol 1997; 15: 535562.
  • 15
    Groux H, O'Garra A, Bigler M et al. A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature 1997; 389: 737742.
  • 16
    Weiner HL. Induction and mechanism of action of transforming growth factor-beta-secreting Th3 regulatory cells. Immunol Rev 2001; 182: 207214.
  • 17
    Chang CC, Ciubotariu R, Manavalan JS et al. Tolerization of dendritic cells by T (S) cells: the crucial role of inhibitory receptors ILT3 and ILT4. Nat Immunol 2002; 3: 237243.
  • 18
    Zhang ZX, Yang L, Young KJ et al. Identification of a previously unknown antigen-specific regulatory T cell and its mechanism of suppression. Nat Med 2000; 6: 782789.
  • 19
    Lechler R, Chai JG, Marelli-Berg F, Lombardi G. T-cell anergy and peripheral T-cell tolerance. Philos Trans R Soc Lond B Biol Sci 2001; 356: 625637.
  • 20
    MacDonald HR. Development and selection of NKT cells. Curr Opin Immunol 2002; 14: 250254.
  • 21
    Benlagha K, Kyin T, Beavis A et al. A thymic precursor to the NK T cell lineage. Science 2002; 296: 553555.
  • 22
    Pellicci DG, Hammond KJ, Uldrich AP et al. A natural killer T (NKT) cell developmental pathway involving a thymus-dependent NK1.1 (-) CD4 (+) CD1d-dependent precursor stage. J Exp Med 2002; 195: 835844.
  • 23
    Hong S, Wilson MT, Serizawa I et al. The natural killer T-cell ligand alpha-galactosylceramide prevents autoimmune diabetes in non-obese diabetic mice. Nat Med 2001; 7: 10521056.
  • 24
    Sharif S, Arreaza GA, Zucker P et al. Activation of natural killer T cells by alpha-galactosylceramide treatment prevents the onset and recurrence of autoimmune Type 1 diabetes. Nat Med 2001; 7: 10571062.
  • 25
    Miyamoto K, Miyake S, Yamamura T. A synthetic glycolipid prevents autoimmune encephalomyelitis by inducing TH2 bias of natural killer T cells. Nature 2001; 413: 531534.
  • 26
    Singh AK, Wilson MT, Hong S et al. Natural killer T cell activation protects mice against experimental autoimmune encephalomyelitis. J Exp Med 2001; 194: 18011811.
  • 27
    Zeng D, Lee MK, Tung J et al. A role for CD1 in the pathogenesis of lupus in NZB/NZW mice. J Immunol 2000; 164: 50005004.
  • 28
    Wilson SB, Kent SC, Patton KT et al. Extreme Th1 bias of invariant Valpha24JalphaQ T cells in type 1 diabetes. Nature 1998; 391: 177181.
  • 29
    Lee PT, Putnam A, Benlagha K et al. Testing the NKT cell hypothesis of human IDDM pathogenesis. J Clin Invest 2002; 110: 793800.
  • 30
    Sumida T, Sakamoto A, Murata H et al. Selective reduction of T cells bearing invariant V alpha 24J alpha Q antigen receptor in patients with systemic sclerosis. J Exp Med 1995; 182: 11631168.
  • 31
    Terabe M, Matsui S, Noben-Trauth N et al. NKT cell-mediated repression of tumor immunosurveillance by IL-13 and the IL-4R-STAT6 pathway. Nat Immunol 2000; 1: 515520.
  • 32
    Moodycliffe AM, Nghiem D, Clydesdale G, Ullrich SE. Immune suppression and skin cancer development: regulation by NKT cells. Nat Immunol 2000; 1: 521525.
  • 33
    Smyth MJ, Crowe NY, Hayakawa Y et al. NKT cells – conductors of tumor immunity? Curr Opin Immunol 2002; 14: 165171.
  • 34
    Gonzalez-Aseguinolaza G, Van Kaer L, Bergmann CC et al. Natural killer T cell ligand alpha-galactosylceramide enhances protective immunity induced by malaria vaccines. J Exp Med 2002; 195: 617624.
  • 35
    Zeng D, Lewis D, Dejbakhsh-Jones S et al. Bone marrow NK1.1 (-) and NK1.1 (+) T cells reciprocally regulate acute graft versus host disease. J Exp Med 1999; 189: 10731081.
  • 36
    Seino KI, Fukao K, Muramoto K et al. Requirement for natural killer T (NKT) cells in the induction of allograft tolerance. Proc Natl Acad Sci U S A 2001; 98: 25772581.
  • 37
    Sonoda KH, Taniguchi M, Stein-Streilein J. Long-term survival of corneal allografts is dependent on intact CD1d-reactive NKT cells. J Immunol 2002; 168: 20282034.
  • 38
    Levings MK, Sangregorio R, Galbiati F et al. IFN-alpha and IL-10 induce the differentiation of human type 1 T regulatory cells. J Immunol 2001; 166: 55305539.
  • 39
    Barrat FJ, Cua DJ, Boonstra A et al. In vitro generation of interleukin 10-producing regulatory CD4 (+) T cells is induced by immunosuppressive drugs and inhibited by T helper type 1 (Th1)- and Th2-inducing cytokines. J Exp Med 2002; 195: 603616.
  • 40
    Jonuleit H, Schmitt E, Schuler G et al. Induction of interleukin 10-producing, nonproliferating CD4 (+) T cells with regulatory properties by repetitive stimulation with allogeneic immature human dendritic cells. J Exp Med 2000; 192: 12131222.
  • 41
    Gilliet M, Liu YJ. Generation of human CD8 T regulatory cells by CD40 ligand-activated plasmacytoid dendritic cells. J Exp Med 2002; 195: 695704.
  • 42
    Dhodapkar MV, Steinman RM. Antigen-bearing immature dendritic cells induce peptide-specific CD8 (+) regulatory T cells in vivo in humans. Blood 2002; 100: 174177.
  • 43
    Akbari O, DeKruyff RH, Umetsu DT. Pulmonary dendritic cells producing IL-10 mediate tolerance induced by respiratory exposure to antigen. Nat Immunol 2001; 2: 725731.
  • 44
    Akbari O, Freeman GJ, Meyer EH et al. Antigen-specific regulatory T cells develop via the ICOS-ICOS-ligand pathway and inhibit allergen-induced airway hyperreactivity. Nat Med 2002; 8: 10241032.
  • 45
    Zheng SG, Gray JD, Ohtsuka K et al. Generation Ex Vivo of TGF-beta-Producing Regulatory T Cells from CD4 (+) CD25 (-) Precursors. J Immunol 2002; 169: 41834189.
  • 46
    Akiyama Y, Shirasugi N, Aramaki O et al. Intratracheal delivery of a single major histocompatibility complex class I peptide induced prolonged survival of fully allogeneic cardiac grafts and generated regulatory cells. Hum Immunol 2002; 63: 888892.
  • 47
    Ford MS, Young KJ, Zhang Z et al. The immune regulatory function of lymphoproliferative double negative T cells in vitro and in vivo. J Exp Med 2002; 196: 261267.
  • 48
    Kawabe Y, Ochi A. Selective anergy of V beta 8+,CD4+ T cells in Staphylococcus enterotoxin B-primed mice. J Exp Med 1990; 172: 10651070.
  • 49
    Lombardi G, Sidhu S, Batchelor R, Lechler R. Anergic T cells as suppressor cells in vitro. Science 1994; 264: 15871589.
  • 50
    Frasca L, Carmichael P, Lechler R, Lombardi G. Anergic T cells effect linked suppression. Eur J Immunol 1997; 27: 31913197.
  • 51
    Chai JG, Bartok I, Chandler P et al. Anergic T cells act as suppressor cells in vitro and in vivo. Eur J Immunol 1999; 29: 686692.
  • 52
    Vendetti S, Chai JG, Dyson J et al. Anergic T cells inhibit the antigen-presenting function of dendritic cells. J Immunol 2000; 165: 11751181.
  • 53
    Graca L, Thompson S, Lin CY et al. Both CD4 (+) CD25 (+) and CD4 (+) CD25 (-) regulatory cells mediate dominant transplantation tolerance. J Immunol 2002; 168: 55585565.
  • 54
    Powrie F, Correa-Oliveira R, Mauze S, Coffman RL. Regulatory interactions between CD45RBhigh and CD45RBlow CD4+ T cells are important for the balance between protective and pathogenic cell-mediated immunity. J Exp Med 1994; 179: 589600.
  • 55
    Seddon B, Mason D. Regulatory T cells in the control of autoimmunity: the essential role of transforming growth factor beta and interleukin 4 in the prevention of autoimmune thyroiditis in rats by peripheral CD4 (+) CD45RC- cells and CD4 (+) CD8 (–) thymocytes. J Exp Med 1999; 189: 279288.
  • 56
    Papiernik M, De Moraes ML, Pontoux C et al. Regulatory CD4 T cells: expression of IL-2R alpha chain, resistance to clonal deletion and IL-2 dependency. Int Immunol 1998; 10: 371378.
  • 57
    Modigliani Y, Thomas-Vaslin V, Bandeira A et al. Lymphocytes selected in allogeneic thymic epithelium mediate dominant tolerance toward tissue grafts of the thymic epithelium haplotype. Proc Natl Acad Sci U S A 1995; 92: 75557559.
  • 58
    Bensinger SJ, Bandeira A, Jordan MS et al. Major histocompatibility complex class II-positive cortical epithelium mediates the selection of CD4 (+) 25 (+) immunoregulatory T cells. J Exp Med 2001; 194: 427438.
  • 59
    Jordan MS, Boesteanu A, Reed AJ et al. Thymic selection of CD4+CD25+ regulatory T cells induced by an agonist self-peptide. Nat Immunol 2001; 2: 301306.
  • 60
    Malek TR, YuA. Vincek V, Scibelli P, Kong L. CD4 regulatory T cells prevent lethal autoimmunity in IL-2Rbeta-deficient mice. Implications for the nonredundant function of IL-2. Immunity 2002; 17: 167178.
  • 61
    Furtado GC, De Lafaille MA, Kutchukhidze N, Lafaille JJ. Interleukin 2 signaling is required for CD4 (+) regulatory T cell function. J Exp Med 2002; 196: 851857.
  • 62
    Salomon B, Lenschow DJ, Rhee L et al. B7/CD28 costimulation is essential for the homeostasis of the CD4+CD25+ immunoregulatory T cells that control autoimmune diabetes. Immunity 2000; 12: 431440.
  • 63
    Green EA, Choi Y, Flavell RA. Pancreatic lymph node-derived CD4 (+) CD25 (+) Treg cells: highly potent regulators of diabetes that require TRANCE-RANK signals. Immunity 2002; 16: 183191.
  • 64
    Bystry RS, Aluvihare V, Welch KA et al. B cells and professional APCs recruit regulatory T cells via CCL4. Nat Immunol 2001; 2: 11261132.
  • 65
    Szanya V, Ermann J, Taylor C et al. The subpopulation of CD4+CD25+ splenocytes that delays adoptive transfer of diabetes expresses 1-selectin and high levels of CCR7. J Immunol 2002; 169: 24612465.
  • 66
    Iellem A, Mariani M, Lang R et al. Unique chemotactic response profile and specific expression of chemokine receptors CCR4 and CCR8 by CD4 (+) CD25 (+) regulatory T cells. J Exp Med 2001; 194: 847853.
  • 67
    Ng WF, Duggan PJ, Ponchel F et al. Human CD4 (+) CD25 (+) cells: a naturally occurring population of regulatory T cells. Blood 2001; 98: 27362744.
  • 68
    Dieckmann D, Plottner H, Berchtold S et al. Ex vivo isolation and characterization of CD4 (+) CD25 (+) T cells with regulatory properties from human blood. J Exp Med 2001; 193: 13031310.
  • 69
    Jonuleit H, Schmitt E, Stassen M et al. Identification and functional characterization of human CD4 (+) CD25 (+) T cells with regulatory properties isolated from peripheral blood. J Exp Med 2001; 193: 12851294.
  • 70
    Levings MK, Sangregorio R, Roncarolo MG. Human cd25 (+) cd4 (+) t regulatory cells suppress naive and memory T cell proliferation and can be expanded in vitro without loss of function. J Exp Med 2001; 193: 12951302.
  • 71
    Baecher-Allan C, Brown JA, Freeman GJ. Hafler DA. CD4+CD25high regulatory cells in human peripheral blood. J Immunol 2001; 167: 12451253.
  • 72
    Annunziato F, Cosmi L, Liotta F et al. Phenotype, localization, and mechanism of suppression of CD4 (+) CD25 (+) human thymocytes. J Exp Med 2002; 196: 379387.
  • 73
    Murakami M, Sakamoto A, Bender J et al. CD25+CD4+ T cells contribute to the control of memory CD8+ T cells. Proc Natl Acad Sci U S A 2002; 99: 88328837.
  • 74
    Piccirillo CA, Shevach EM. Control of CD8+ T cell activation by CD4+CD25+ immunoregulatory cells. J Immunol 2001; 167: 11371140.
  • 75
    Thornton AM, Shevach EM. Suppressor effector function of CD4+CD25+ immunoregulatory T cells is antigen nonspecific. J Immunol 2000; 164: 183190.
  • 76
    Takahashi T, Tagami T, Yamazaki S et al. Immunologic self-tolerance maintained by CD25 (+) CD4 (+) regulatory T cells constitutively expressing cytotoxic T lymphocyte-associated antigen 4. J Exp Med 2000; 192: 303310.
  • 77
    Read S, Malmstrom V, Powrie F. Cytotoxic T lymphocyte-associated antigen 4 plays an essential role in the function of CD25 (+) CD4 (+) regulatory cells that control intestinal inflammation. J Exp Med 2000; 192: 295302.
  • 78
    Kingsley CI, Karim M, Bushell AR, Wood KJ. CD25+CD4+ regulatory T cells prevent graft rejection. CTLA-4- and IL-10-dependent immunoregulation of alloresponses. J Immunol 2002; 168: 10801086.
  • 79
    Nakamura K, Kitani A, Strober W. Cell contact-dependent immunosuppression by CD4 (+) CD25 (+) regulatory T cells is mediated by cell surface-bound transforming growth factor beta. J Exp Med 2001; 194: 629644.
  • 80
    Asseman C, Mauze S, Leach MW et al. An essential role for interleukin 10 in the function of regulatory T cells that inhibit intestinal inflammation. J Exp Med 1999; 190: 9951004.
  • 81
    Jonuleit H, Schmitt E, Kakirman H et al. Infectious tolerance: human CD25 (+) regulatory T cells convey suppressor activity to conventional CD4 (+) T helper cells. J Exp Med 2002; 196: 255260.
  • 82
    Dieckmann D, Bruett CH, Ploettner H et al. Human CD4 (+) CD25 (+) regulatory, contact-dependent T cells induce interleukin 10-producing, contact-independent type 1-like regulatory T cells. J Exp Med 2002; 196: 247253.
  • 83
    Zuany-Amorim C, Sawicka E, Manlius C et al. Suppression of airway eosinophilia by killed Mycobacterium vaccae-induced allergen-specific regulatory T-cells. Nat Med 2002; 8: 625629.
  • 84
    Kullberg MC, Jankovic D, Gorelick PL et al. Bacteria-triggered CD4 (+) T regulatory cells suppress Helicobacter hepaticus-induced colitis. J Exp Med 2002; 196: 505515.
  • 85
    Hoffmann P, Ermann J, Edinger M et al. Donor-type CD4 (+) CD25 (+) regulatory T cells suppress lethal acute graft-versus-host disease after allogeneic bone marrow transplantation. J Exp Med 2002; 196: 389399.
  • 86
    Yamagiwa S, Gray JD, Hashimoto S. Horwitz DA. A role for TGF-beta in the generation and expansion of CD4+CD25+ regulatory T cells from human peripheral blood. J Immunol 2001; 166: 72827289.
  • 87
    Shimizu J, Yamazaki S, Takahashi T et al. Stimulation of CD25 (+) CD4 (+) regulatory T cells through GITR breaks immunological self-tolerance. Nat Immunol 2002; 3: 135142.
  • 88
    McHugh RS, Whitters MJ, Piccirillo CA et al. CD4 (+) CD25 (+) immunoregulatory T cells: gene expression analysis reveals a functional role for the glucocorticoid-induced TNF receptor. Immunity 2002; 16: 311323.
  • 89
    Zelenika D, Adams E, Humm S et al. Regulatory T cells overexpress a subset of Th2 gene transcripts. J Immunol 2002; 168: 10691079.
  • 90
    Ronchetti S, Nocentini G, Riccardi C et al. Role of GITR in activation response of T lymphocytes. Blood 2002; 100: 350352.
  • 91
    Baecher-Allan C, Viglietta V. Hafler DA. Inhibition of human CD4 (+) CD25 (+high) regulatory T cell function. J Immunol 2002; 169: 62106217.
  • 92
    Levings MK, Sangregorio R, Sartirana C et al. Human CD25+CD4+ T suppressor cell clones produce transforming growth factor β, but not interleukin 10, and are distinct from type 1 t regulatory cells. J Exp Med 2002; 196: 13351346.
  • 93
    Seddon B, Mason D. Peripheral autoantigen induces regulatory T cells that prevent autoimmunity. J Exp Med 1999; 189: 877882.
  • 94
    Van Maurik A, Herber M, Wood KJ et al. CD4 (+) CD25 (+) alloantigen-specific immunoregulatory cells that can prevent CD8 (+) T cell-mediated graft rejection: implications for anti-CD154 immunotherapy. J Immunol 2002; 169: 54015404.
  • 95
    Cohen JL, Trenado A, Vasey D et al. CD4 (+) CD25 (+) immunoregulatory T Cells: new therapeutics for graft-versus-host disease. J Exp Med 2002; 196: 401406.
  • 96
    Faunce DE, Stein-Streilein J. NKT cell-derived RANTES recruits APCs and CD8+ T cells to the spleen during the generation of regulatory T cells in tolerance. J Immunol 2002; 169: 3138.
  • 97
    Beaudoin L, Laloux V, Novak J et al. NKT cells inhibit the onset of diabetes by impairing the development of pathogenic T cells specific for pancreatic Beta cells. Immunity 2002; 17: 725736.
  • 98
    Lin CY, Graca L, Cobbold SP, Waldmann H. Dominant transplantation tolerance impairs CD8+ T cell function but not expansion. Nat Immunol 2002; 3: 12081213.
  • 99
    Belkaid Y, Piccirillo CA, Mendez S et al. CD4+CD25+ regulatory T cells control Leishmania major persistence and immunity. Nature 2002; 420: 502507.
  • 100
    Xu D, Liu H, Komai-Koma, M, Campbell C et al. CD4 (+) CD25 (+) Regulatory T Cells Suppress Differentiation and Functions of Th1 and Th2 Cells, Leishmania major Infection, and Colitis in Mice. J Immunol 2003; 170: 394399.